Trial Profile
Open Label Study to Assess the Pharmacokinetics of GSK1278863A Coadministered With a High Fat Meal or an Inhibitor of CYP2C8 (Gemfibrozil)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Jun 2023
Price :
$35
*
At a glance
- Drugs Daprodustat (Primary) ; Gemfibrozil
- Indications Anaemia
- Focus Pharmacokinetics
- Sponsors GSK
- 17 Nov 2014 New trial record